Wegovy is given in higher doses compared to Ozempic for the purpose of chronic weight management
The market Obesity and type-2 diabetes remain expanding markets
How GLP-1 and Dual GIP/GLP-1 Agonists Work to Treat Obesity GLP-1 agonists and dual GIP/GLP-1 agonists are medications that increase satiety (the feeling of fullness), slow digestion, and quiet constant thoughts about food (known as food noise), making it easier to lose weight and keep it off
It is beneficial to get this boost before you exercise to maintain muscle, lose flab, and tighten your abs
Higher doses should be administered only with caution and only where clinical and biochemical considerations make it seem likely that higher doses will be of benefit
Zhang M, Niu W, Wang Y, et al